Infosys shares slide to 52-week low: FY27 view 2026

Stock extends sell-off for a fifth session

Infosys Ltd shares continued to weaken, falling for the fifth straight session on Tuesday. The stock dropped as much as 1.7% in early trade. At last check, it was trading 1.15% lower at Rs 1,173.60 on the BSE versus the previous close of Rs 1,187.25. The counter has fallen more than 7.5% over the last six sessions, including Tuesday’s move. The decline comes amid investor focus on guidance, demand conditions, and the pace of AI-led changes in IT services delivery.

Recent trading levels and 52-week lows

The sell-off has also taken the stock to fresh yearly lows in recent sessions. On Friday, Infosys slipped up to 7.2% on the BSE and logged a 52-week low of Rs 1,152.35. It closed that day down 7.09% at Rs 1,154.45. Another market update in the provided data also showed Infosys at Rs 1,187.60, down 0.83% from its previous close (different sources cited previous closes of Rs 1,197.50 and Rs 1,201.3). These variations reflect different timestamps and reference closes, but the common trend is a sustained decline across consecutive sessions.

Q4 FY26 results: profit up, market reaction negative

The sharpest fall in the set followed the company’s March-quarter (Q4) results. Infosys shares slumped over 6% to an intraday low of Rs 1,163 on the NSE on Friday after it reported a 21% year-on-year rise in consolidated net profit for the quarter ended March 31, 2026. Net profit came in at Rs 8,501 crore versus Rs 7,033 crore in the same period last year. Despite the profit growth, the stock reaction pointed to investor concern about growth and margins rather than the bottom line print alone. The data also notes the ADR fell 4.01% overnight following the earnings release.

FY27 guidance and what the market is reacting to

A key driver cited in the article set is guidance for FY27. Infosys guided for FY27 revenue growth of 1.5% to 3.5% in constant currency terms. It also maintained adjusted EBIT margin guidance in the 20% to 22% range. Some commentary in the provided data describes the Q4 outcome as “strong profits but weak guidance”, which likely shaped sentiment even as profits rose year-on-year. The same set of notes also flags macro uncertainties and the impact of AI on demand and pricing, themes that have become recurring in brokerage commentary on large-cap IT.

Brokerage calls: Buy ratings remain, but targets are mixed

Brokerage views in the provided text show a wide spread of targets and ratings. JM Financial retained a ‘Buy’ on Infosys after a management meeting, with a 12-month target price of Rs 1,410 per share and indicated about 20% upside from current levels. Another domestic brokerage maintained a Buy with an unchanged target price of Rs 1,450, implying a 17% upside from current levels. Motilal Oswal appears multiple times in the dataset with Buy calls and different targets in different notes, including Rs 1,425, Rs 1,450, and Rs 1,550. HSBC is cited with a Buy rating and a target of Rs 1,585, while Nomura reiterated a Buy with a target of Rs 1,640, implying upside of over 33%.

Holds and neutrals: targets cut after results

Several global brokerages in the text maintained cautious stances while cutting targets. Citi retained a ‘neutral’ call and cut its target price to Rs 1,300 per share, citing weak Q4 performance with misses on revenue and EBIT margin. Jefferies maintained a ‘hold’ rating with a target price of Rs 1,235, and another line also describes a global brokerage with a Hold rating and a cut target price to Rs 1,235. A Wall Street major maintained an Equal-weight rating and cut its target price to Rs 1,380 from Rs 1,760 earlier, noting that a sharp reduction in headcount during the quarter aligned with a cautious growth outlook. These calls reinforce the point in the input that analysts are divided, with many lowering targets due to macro uncertainty and AI-linked business model shifts.

Valuations and downside support arguments

One brokerage note in the dataset highlighted that valuations are correcting closer to peer levels. It also said this may offer some downside protection, with the stock valued at around 15.8 times price-to-earnings. Another note suggested dividend yield may limit downside, while weak growth could cap upside. While such framing does not remove near-term uncertainty, it helps explain why Buy ratings have persisted even as targets have been trimmed by several houses. The split between “valuation support” and “growth risk” is a central feature of the current Infosys debate in the provided text.

Market impact: price, sentiment, and positioning

The immediate market impact has been visible in the stock’s multi-session decline and new 52-week lows. Reports in the dataset also reference market-cap levels during the sell-off, including a mention of capitalization “barely holding” the Rs 4.8 lakh crore mark in one instance and a separate reference to Rs 5.55 lakh crore on another day when the stock fell intraday from Rs 1,401.85 to Rs 1,365.65. The price action suggests investors are repricing the stock around FY27 growth expectations and the perceived persistence of pricing pressure. The repeated references to AI’s impact and macro uncertainty indicate that the discussion has broadened beyond one quarter’s numbers to medium-term delivery and demand risks.

Key facts snapshot

Brokerage targets and ratings mentioned

Why this matters for investors tracking Indian IT

The Infosys move matters because it highlights how guidance and demand commentary can outweigh headline profit growth for IT services stocks. The range of targets from Rs 1,235 to Rs 1,640 in the provided data shows meaningful disagreement on the earnings trajectory and the degree of AI-led disruption or opportunity. At the same time, the recurrence of Buy ratings suggests parts of the Street see valuation support after the correction and expect stability as visibility improves. The next important inputs, based on the themes cited, will be how deal ramps, pricing, and margin delivery track within the 20% to 22% band and whether constant-currency growth stays within the 1.5% to 3.5% guidance.